Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the INVOcell Intravaginal Culture System During 5-day (120 Hours) Vaginal Incubation

NCT04246268 is registered in ClinicalTrials.gov with INVO Bioscience, Inc. as lead sponsor.

NCT NCT04246268
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04246268 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the INVOcell Intravaginal Culture System During 5-day (120 Hours) Vaginal Incubation
Lead sponsor
INVO Bioscience, Inc.
Phase
Not applicable
Overall status
Suspended
Start date
October 31, 2020
Completion date
March 31, 2022
Enrollment
180 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

infertility